Fidelity International
BLUE

Fidelity International’s bluebird bio BLUE Stock Holding History

Fidelity International’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,342
Closed -$2.73M – 895
2019
Q1 		$2.73M Sell
1,342
-375
-22% -$660K ﹤0.01% 557
2018
Q4 		$2.21M Sell
1,717
-15,700
-90% -$24.1M ﹤0.01% 573
2018
Q3 		$32.9M Buy
17,417
+10,847
+165% +$22.4M 0.05% 324
2018
Q2 		$13.4M Buy
+6,570
New +$15M 0.02% 455

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International's BLUE Position: Q2 2019 in Review

Fidelity International sold out of bluebird bio (BLUE) in Q2 2019, closing a stake of 1,342 shares — an estimated $2.73M sold.

Fidelity International first reported a position in BLUE in Q2 2018 and held it in 4 quarters. The position peaked at $32.9M in Q3 2018. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

  • Fidelity International reported no remaining bluebird bio position as of Q2 2019 after selling out during the quarter.
  • Fidelity International sold 1,342 bluebird bio shares in Q2 2019, an estimated $2.73M.
  • Fidelity International first reported a position in bluebird bio in Q2 2018 and held it in 4 quarters.
  • Fidelity International's bluebird bio position peaked at $32.9M in Q3 2018.
  • 273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Fidelity International's 13F filing for Q2 2019, filed 13 Aug 2019.